These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 31778110)

  • 21. Development of a droplet digital PCR for pertussis toxin locus copy number determination in a genetically-modified Bordetella pertussis strain.
    Esson R; Falque S; Abachin E; George S; Nougarede N
    Biologicals; 2023 May; 82():101683. PubMed ID: 37149976
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of pertussigen (pertussis toxin) on the mouse protective activity of vaccines made from Bordetella species.
    Munoz JJ; Peacock MG
    Microbiol Immunol; 1989; 33(4):341-55. PubMed ID: 2549344
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Evaluation of whole-cell and acellular pertussis vaccines effectiveness in clearance of experimental B. pertussis infection in mice].
    Gzyl A; Augustynowicz E; Zawadka M; Rabczenko D; Slusarczyk J
    Med Dosw Mikrobiol; 2007; 59(2):123-35. PubMed ID: 17929410
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differences of circulating Bordetella pertussis population in Argentina from the strain used in vaccine production.
    Fingermann M; Fernández J; Sisti F; Rodríguez ME; Gatti B; Bottero D; Graieb A; Gaillard ME; Ayala SG; Mooi FR; Lopardo H; Hozbor D
    Vaccine; 2006 Apr; 24(17):3513-21. PubMed ID: 16545509
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of Bordetella pertussis pertactin and pertussis toxin types from Queensland, Australia, 1999-2003.
    Byrne S; Slack AT
    BMC Infect Dis; 2006 Mar; 6():53. PubMed ID: 16542440
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of a key neutralizing epitope on pertussis toxin recognized by monoclonal antibody 1B7.
    Sutherland JN; Maynard JA
    Biochemistry; 2009 Dec; 48(50):11982-93. PubMed ID: 19899804
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Construction and characterization of genetically inactivated pertussis toxin.
    Brown DR; Keith JM; Sato H; Sato Y
    Dev Biol Stand; 1991; 73():63-73. PubMed ID: 1778335
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bordetella pertussis vaccine strains and circulating isolates in Serbia.
    Dakic G; Kallonen T; Elomaa A; Pljesa T; Vignjevic-Krastavcevic M; He Q
    Vaccine; 2010 Feb; 28(5):1188-92. PubMed ID: 19945417
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Engineering bacterial toxin for the development of new vaccine against pertussis.
    Bartoloni A; Pizza M; Gross R; Perugini M; Arico B; Domenighini M; Rappuoli R
    Tokai J Exp Clin Med; 1988; 13 Suppl():217-22. PubMed ID: 2483870
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The advent of recombinant pertussis vaccines.
    Burnette WN
    Biotechnology (N Y); 1990 Nov; 8(11):1002-5. PubMed ID: 1366927
    [No Abstract]   [Full Text] [Related]  

  • 31. Neonatal immunization with a single dose of recombinant BCG expressing subunit S1 from pertussis toxin induces complete protection against Bordetella pertussis intracerebral challenge.
    Nascimento IP; Dias WO; Quintilio W; Christ AP; Moraes JF; Vancetto MD; Ribeiro-Dos-Santos G; Raw I; Leite LC
    Microbes Infect; 2008 Feb; 10(2):198-202. PubMed ID: 18248757
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of mutant strains producing pertussis toxin cross reacting materials.
    Sato Y; Sato H; Chazono M; Ginnaga A; Tamura C
    Dev Biol Stand; 1991; 73():93-107. PubMed ID: 1778339
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Application of DNA microcarriers for evaluation of mice splenocytes genes expression after immunization with pertussis vaccines and challenged with different B. pertussis strains].
    Gzyl A; Woyciechowska-Oczko M; Jarzab B; Augustynowicz E; Mosiej E; Slusarczyk J
    Med Dosw Mikrobiol; 2007; 59(2):149-59. PubMed ID: 17929412
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protective immunogenicity of synthetic peptides selected from the amino acid sequence of Bordetella pertussis toxin subunit S1.
    Askelöf P; Rodmalm K; Wrangsell G; Larsson U; Svenson SB; Cowell JL; Undén A; Bartfai T
    Dev Biol Stand; 1991; 73():111-20. PubMed ID: 1778305
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sequence variation in pertussis S1 subunit toxin and pertussis genes in Bordetella pertussis strains used for the whole-cell pertussis vaccine produced in Poland since 1960: efficiency of the DTwP vaccine-induced immunity against currently circulating B. pertussis isolates.
    Gzyl A; Augustynowicz E; Gniadek G; Rabczenko D; Dulny G; Slusarczyk J
    Vaccine; 2004 Jun; 22(17-18):2122-8. PubMed ID: 15149768
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proteome Analysis Is a Valuable Tool to Monitor Antigen Expression during Upstream Processing of Whole-Cell Pertussis Vaccines.
    Metz B; Hoonakker M; Uittenbogaard JP; Weyts M; Mommen GP; Meiring HD; Tilstra W; Pennings JL; van der Pol LA; Kuipers B; Sloots A; van den IJssel J; van de Waterbeemd B; van der Ark A
    J Proteome Res; 2017 Feb; 16(2):528-537. PubMed ID: 27977922
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic exchange of the S2 and S3 subunits in pertussis toxin.
    Raze D; Veithen A; Sato H; Antoine R; Menozzi FD; Locht C
    Mol Microbiol; 2006 Jun; 60(5):1241-50. PubMed ID: 16689799
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Investigating pertussis toxin and its impact on vaccination.
    Coutte L; Locht C
    Future Microbiol; 2015; 10(2):241-54. PubMed ID: 25689536
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular aspects of Bordetella pertussis pathogenesis.
    Locht C
    Int Microbiol; 1999 Sep; 2(3):137-44. PubMed ID: 10943406
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of Bordetella pertussis isolates collected in Japan before and after introduction of acellular pertussis vaccines.
    Guiso N; Boursaux-Eude C; Weber C; Hausman SZ; Sato H; Iwaki M; Kamachi K; Konda T; Burns DL
    Vaccine; 2001 Apr; 19(23-24):3248-52. PubMed ID: 11312021
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.